| 1 |
孙瑞琼，王 爽. 原发性肺黏液腺癌多层螺旋CT影像表现[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(2): 260-262.
|
| 2 |
Travis WD, Brambilla E, Burke AP, et al. Introduction to the 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart[J]. J Thorac Oncol, 2015, 10(9): 1240-1242.
|
| 3 |
Türüt H, Demirag F, Gulhan E, et al. Primary pulmonary mucinous adenocarcinoma in a 15-year-old boy[J]. Eur J Cardiothorac Surg, 2006, 29(5): 851-853.
|
| 4 |
Babiy Y, Sychova T, Dykan I. Radiological aspects of the new "International multidisciplinary classification of lung adenocarcinoma" ：Methodological bases and own experience[J]. Radiation Diagnostics Radiation Therapy, 2019(4): 55-71.
|
| 5 |
Choi Y, Kim KH, Jeong BH, et al. Clinicoradiopathological features and prognosis according to genomic alterations in patients with resected lung adenocarcinoma[J]. J Thorac Dis, 2020, 12(10): 5357-5368.
|
| 6 |
Blackstone N, El-Aini T. Medical image of the month: Mucinous adenocarcinoma of the lung mimicking pneumonia[J]. Southwest J Pulmonary and Cri Care, 2021, 22(1)：8-10.
|
| 7 |
Shim HS, Kenudson M, Zheng Z, et al. Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung[J]. J Thorac Oncol, 2015, 10(8): 1156-1162.
|
| 8 |
Geles A, Gruber-Moesenbacher U, Quehenberger F, et al. Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival[J]. Virchows Arch, 2015, 467(6): 675-686.
|
| 9 |
Austin JH, Garg K, Aberle D, et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung[J]. Radiology, 2013, 266(1): 62-71.
|
| 10 |
Shenoy V, Buckley M, Hosseini H, et al. S1710 signet ring cell mucinous adenocarcinoma of the colon manifesting as intermittent hiccups[J]. Official J American College of Gastroenterology ACG, 2020, 115(1): 882-883.
|
| 11 |
Sun F, Wang P, Zheng Y, et al. Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma[J]. Oncol Lett, 2018, 15(1): 489-494.
|
| 12 |
周 蕾. 79例肺原发性粘液腺癌的临床分析[D]. 大连医科大学，2017: 1-5.
|
| 13 |
魏朋华. 原发性肺粘液腺癌的临床病理及分子特征的回顾性分析[D]. 山东大学，2020: 3-8.
|
| 14 |
Moon SW, Choi SY, Moon MH. Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study[J]. J Thorac Dis, 2018, 10(6): 3595-3608.
|
| 15 |
Boland JM, Maleszewski JJ, Wampfler JA, et al. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis[J]. Hum Pathol, 2018, 71: 8-19.
|
| 16 |
Cha YJ, Kim HR, Lee HJ, et al. Clinical course of stage Ⅳ invasive mucinous adenocarcinoma of the lung[J]. Lung Cancer, 2016, 102: 82-88.
|
| 17 |
Kim DH, Bae SY, Na KJ, et al. Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma[J]. Interact Cardiovasc Thorac Surg, 2022, 34(2): 229-235.
|
| 18 |
Blackstone N, El-Aini T. Medical image of the month: Mucinous adenocarcinoma of the lung mimicking pneumonia[J]. Southwest J Pulmonary and Critical Care, 2021, 22(1): 8-10.
|
| 19 |
Perre SV, Duron L, Milon A, et al. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions[J]. Eur Radiol, 2021, 31(7): 4848-4859.
|
| 20 |
Nakaoku T, Tsuta K, Ichikawa H, et al. Druggable oncogene fusions in invasive mucinous lung adenocarcinoma[J]. Clin Cancer Res, 2014, 20(12): 3087-3093.
|
| 21 |
Shin DH, Lee D, Hong DW, et al. Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung[J]. Oncotarget, 2016, 7(43): 69450-69465.
|
| 22 |
Laskin J, Liu SV, Tolba K, et al. NRG1 fusion－driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents[J]. Ann Oncol, 2020, 31(12): 1693-1703.
|
| 23 |
Guo M, Tomoshige K, Meister M, et al. Gene signature driving invasive mucinous adenocarcinoma of the lung[J]. EMBO Mol Med, 2017, 9(4): 462-481.
|
| 24 |
Duruisseaux M, Antoine M, Rabbe N, et al. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers[J]. Lung Cancer, 2017, 109: 92-100.
|
| 25 |
Milewski D, Balli D, Ustiyan V, et al. FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas[J]. PLoS Genet, 2017, 13(12): e1007097.
|
| 26 |
Truini A, Santos Pereira P, Cavazza A, et al. Classification of different patterns of pulmonary adenocarcinomas[J]. Expert Rev Respir Med, 2015, 9(5): 571-586.
|
| 27 |
Lantuejoul S, Rouquette I, Brambilla E, et al. [New WHO classification of lung adenocarcinoma and preneoplasia][J]. Ann Pathol, 2016, 36(1): 5-14.
|
| 28 |
Lee HJ, Lee CH, Jeong YJ, et al. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications[J]. J Thorac Imaging, 2012, 27(6): 340-353.
|
| 29 |
Kuhn E, Morbini P, Cancellieri A, et al. Adenocarcinoma classification：patterns and prognosis[J]. Pathologica, 2018, 110(1): 5-11.
|
| 30 |
Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma[J]. J Thorac Oncol, 2011, 6(2): 244-285.
|